A Familiar Leading Pack Conceals Changes For Off-Patent Industry Leaders
Generics Bulletin’s Top 50 Ranking Of Generics And Biosimilars Firms For 2024
Our latest ranking of the world’s leading off-patent companies reflects a fairly stable leading group this year – but this belies the significant evolutions seen for major generics and biosimilars players over the past 12 months.
